¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phosphate potential"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cutaneous nerve somatosensory evoked potential
    ÇǺνŰæ¸ö°¨°¢À¯¹ßÀüÀ§
  • demarcation potential
    ºÐ°èÀüÀ§
  • denervation potential
    Å»½Å°æÀüÀ§
  • diffusion potential
    È®»êÀüÀ§
  • disease potential
    Áúº´ÀáÀç·Â
  • evoked potential
    À¯¹ßÀüÀ§
  • excitatory junctional potential
    ÈïºÐÁ¢ÇÕºÎÀüÀ§
  • excitatory postsynaptic potential
    ÈïºÐ½Ã³À½ºÀÌÈÄÀüÀ§, ÈïºÐ¿¬Á¢ÀÌÈÄÀüÀ§
  • early receptor potential
    Á¶±â¼ö¿ëüÀüÀ§, Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
  • electric potential
    Àü±âÀüÀ§, ÀüÀ§
  • electric potential gradient
    ÀüÀ§±â¿ï±â
  • electrochemical potential
    Àü±âÈ­ÇÐÀüÀ§
  • electrochemical potential gradient
    Àü±âÈ­ÇÐÀüÀ§±â¿ï±â
  • electrode potential
    Àü±ØÀüÀ§
  • electrotonic potential
    Àü±â±äÀåÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • demarcation potential
    ºÐ°èÀüÀ§
  • denervation potential
    Å»½Å°æÀüÀ§
  • diffusion potential
    È®»êÀüÀ§
  • disease potential
    Áúº´ÀáÀç·Â
  • potential difference
    Àü¾ÐÂ÷, ÀüÀ§Â÷
  • total potential energy difference
    ÃÑÀ§Ä¡¿¡³ÊÁöÂ÷
  • transmembrane potential difference
    ¸·ÀüÀ§Â÷ÀÌ
  • early receptor potential
    Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
  • electric potential
    ˟ˤ
  • electric potential gradient
    ÀüÀ§±â¿ï±â
  • electrochemical potential
    Àü±âÈ­ÇÐÀüÀ§
  • electrochemical potential gradient
    Àü±âÈ­ÇÐÀüÀ§±â¿ï±â
  • electrode potential
    Àü±ØÀüÀ§
  • electrotonic potential
    Àü±â±äÀåÀüÀ§
  • end plate potential
    Á¾ÆÇÀüÀ§, Á¾¸»ÆÇÀüÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • guaiacol phosphate
    Àλê(ìÝß«)°úÀ̾îÄÝ.
  • high energy phosphate bond
    °í¿¡³ÊÁöÀλ꿰°áÇÕ.
  • histamine acid phosphate
    È÷½ºÅ¸¹Î»ê¼ºÀλ꿰
  • histamine phosphate
    ÀλêÈ÷½ºÅ¸¹Î.
  • phosphate
    Àλ꿰(ìÝß«ç¤).
  • phosphate
    Àλ꿰
  • phosphate buffer
    Àλ꿰¿ÏÃæ¾×
  • phosphate dehydrogenase deficiency
    Àλ꿰ݼö¼ÒÈ¿¼Ò°áÇÌÁõ
  • phosphate diabetes
    Àλ꿰´ç´¢
  • phosphate reabsorption
    Àλ꿰ÀçÈí¼ö
  • potassium dihydrogen phosphate
    ÀλêÀ̼ö¼Ò(ì£â©áÈ)Ä®·ý
  • pyridoxal phosphate
    ÀλêÇǸ®µ¶»ì.
  • EP =endocochlear potential
    ¿Í¿ì³»(Á÷·ù)ÀüÀ§
  • EPSP (excitatory postsynaptic potential)
    ÈïºÐ¼º(ýéÝÇàõ)½Ã³³½ºÈÄ(ý­)ÀüÀ§(ï³êÈ), ÈïºÐ¼º ¿¬Á¢(Ö§ïÈ)ÀüÀ§
  • Generator potential
    ±âµ¿ÀüÀ§(ÑÃÔÑï³êÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glucose 6 phosphate dehydrogenase =G 6 PD
    ±Û·çÄÚ¿À½º 6Àλê Å»¼ö ¼ÒÈ¿¼Ò, ±Û·çÄÚ¿À½º-6-ÀÎ»ê µ¥È÷µå·Î°Ô³ªÁ¦.
  • glucose 6 phosphate dehydrogenase def
    ±Û·çÄÚ¿À½º-6-Àλê Å»¼ö¼Ò È¿¼Ò°á
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ½º-6-ÀλêµðÇÏÀ̵å·ÎÀú³×À̽º
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ¿À½º-6-ÀλêÅ»¼ö¼ÒÈ¿¼Ò
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-ÀλêµðÇÏÀÌ µå·ÎÀú³×À̽º °áÇÌ(Áõ)
  • glycerol phosphate
    Àλê±Û¸®¼¼·Ñ.
  • guaiacol phosphate
    Àλê(ìÝß«)°úÀ̾îÄÝ.
  • high energy phosphate bond
    °í¿¡³ÊÁöÀλ꿰°áÇÕ.
  • histamine acid phosphate
    È÷½ºÅ¸¹Î»ê¼ºÀλ꿰
  • histamine phosphate
    ÀλêÈ÷½ºÅ¸¹Î.
  • magnesium ammonium phosphate
    ¾Ï¸ð´½Àλ긶±×³×½·
  • magnesium ammonium phosphate stones
    ¸¶±×³×½· ¾Ï¹¦´½ Àλ꿰¼®(¡­ ×òß«ç¤à´)
  • magnesium phosphate crystal
    Àλ긶±×³×½·°áÁ¤
  • pentose phosphate pathway
    ¿Àź´ç ÀλêÈ­ ¹ÝÀÀ
  • phosphate
    Àλ꿰
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • p-nitrophenyl phosphate
    p-³ªÀÌÆ®·ÎÆä´Ò Àλê(×òß«)
  • pyridoxal phosphate
    ÇǸ®µ¶»ì Àλê(×òß«)
  • pentose phosphate carboxylase
    Àλê(×òß«)ÆæÅ佺 Ä«¸£º¹½Ç·¹À̽º
  • pentose phosphate pathway
    Àλê(×òß«ÆæÅ佺 °æ·Î(ÌèÖØ)
  • phosphate
    Àλ꿰(×òß«ç¤)
  • phosphate acceptor peptide
    Àλê¼ö¿ë(×òß«áôé») ÆéŸÀ̵å
  • phosphate bond energy
    Àλê°áÇÕ(×ò߫̿ùê) ¿¡³ÊÁö
  • phosphate group
    Àλê±â(×òß«Ðñ)
  • phosphate group transfer
    Àλê±â ÀüÀÌ(×òß«Ðñï®ì¹)
  • phosphate regulon
    Àλê(×òß«)·¹±¼·Ð (ÔÒ) phoÁ¶ÀýÀ¯ÀüÀÚ(ðàï½ë¶îîí­)
  • pyridoxal phosphate
    Àλê(×òß«) ÇǸ®µ¶»ì
  • reductive pentose phosphate cycle
    ȯ¿ø¼º(ü½êªàõ) Àλê(×òß«)ÆæÅ佺 ȸ·Î(üÞÖØ)
  • riboflavin phosphate
    ÀÎ»ê ¶óÀ̺¸Çöóºó
  • riboflavin-5'-phosphate
    5` ÀÎ»ê ¶óÀ̺¸Çöóºó
  • undecaprenol phosphate
    ¾ðµ¥Ä«ÇÁ·¹³î Àλê(×òß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AEP acute edematous pancreatitis; artificial endocrine pancreas; auditory evoked potential; average evok...
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
ERP early receptor potential; effective refractory period; elodoisin-related peptide; endoscopic retrogr...
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
LSEP left somatosensory evoked potential; lumbosacral somatosensory evoked potential
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
APD(50) Action potential duration
APD90 Action potential duration
APD(50) Action potential duration at 50
APD(90) Action potential duration at 50% and 90
APD90 action potential durations at 90% repolarization
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • zephiran-trisodium phosphate
    Á¦ÇǶõ-Æ®¸®¼Òµð¿ò ÀÎ»ê ¿°
  • zinc phosphate
    ÀÎ»ê ¾Æ¿¬
  • zinc phosphate cement base
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ® ÀÌÀå
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ®¸¦ »ç¿ëÇÏ¿© Ä¡¾Æ¿¡ Çü¼ºÇÑ ¿Íµ¿¿¡ base¸¦ ±î´Â °Í.
  • absolute potential
    Àý´ë Àü¾Ð, Àý´ë ÀüÀ§
  • action potential
    Ȱµ¿ ÀüÀ§, Ȱµ¿ Àü¾Ð
    ±ÙÀ°¼¼Æ÷ ¶Ç´Â ½Å°æ¼¼Æ÷°¡ ÈïºÐÇÒ ¶§ »ý±â´Â Àü±âÀû Ȱ¼ºÀ¸·Î¼­, Àü±âÀû, È­ÇÐÀû, ±â°èÀû ÀÚ±Ø ¹× ¿Âµµº¯È­ µî¿¡ ÀÇÇÏ¿© »ý±ä´Ù°í »ý°¢Çϰí ÀÖ´Ù.
  • adaptive potential
    ÀûÀÀ ÀáÀç·Â
    µ¿ÀǾî=ada
  • after-potential
    ÈÄ ÀüÀ§ Çö»ó
    ½ºÆÄÀÌÅ© ÀüÀ§ µÚ¿¡ º¼ ¼ö ÀÖ´Â ÀüÀ§ º¯µ¿ÀÌ´Ù. À½¼º ÈÄ ÀüÀ§¿Í ¾ç¼º ÈÄ ÀüÀ§·Î ³ª´¶´Ù. ÀüÀÚ´Â ¿ªÄ¡ÀÇ »ó½Â, ÈÄÀÚ´Â Çϰ­À» ÀÏÀ¸Å²´Ù.
  • body surface potential mapping
    üǥ¸é ÀüÀ§µµ
  • chemical potential
    È­ÇÐ ÀüÀ§, È­ÇÐ Æ÷ÅÙ¼³
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • contact potential difference
    Á¢ÃË ÀüÀ§Â÷
  • disability potential
    Àå¾ÖÀÇ ÀáÀ缺
  • dorsal root potential
    Èı٠Àü¾Ð
  • electric potential difference
    Àü¾Ð ÀüÀ§Â÷
  • electrical potential
    Àü±â·Â, ÀüÀ§
    1. Àü±âÀåÀ» ¸Å°³·Î ÇÏ¿© Á¤ÁöÇÑ ÀüÇÏ¿¡ ÀÛ¿ëÇÏ´Â Èû. 2. ¾î´À ÇÑ Á¡¿¡¼­ Àü±âÀû ÀÛ¿ëÀ» ¹ÌÄ¥ ¼ö ÀÖ´Â ¿¡³ÊÁöÀÇ ¾ç.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
resting potential <physiology> The electrical potential of the inside of a cell, relative to its surroundings. Almost all animal cells are negative inside, resting potentials are in the range 20 to 100mV, 70mV typical.
Resting potentials reflect the action of the sodium pump only indirectly, they are mainly caused by the subsequent diffusion of potassium out of the cell through potassium leak channels. The resting potential is thus close to the Nernst potential for potassium.
See: action potential.
(10 Mar 1998)
membrane potential <physiology> More correctly, transmembrane potential difference: the electrical potential difference across a plasma membrane.
See: resting potential, action potential.
(18 Nov 1997)
chemical potential <chemistry> The work required (in j mol 1) to bring a molecule from a standard state (usually infinitely separated in a vacuum) to a specified concentration.
More usually employed as chemical potential difference, the work required to bring one mole of a substance from a solution at one concentration to another at a different concentration, __ = RT.In (c2/cl). This definition is useful in studies of active transport, note that, for charged molecules, the electrical potential difference must also be considered (see electrochemical potential).
(18 Nov 1997)
miniature end plate potential <physiology> Small fluctuations (typically 0.5 mV) in the resting potential of postsynaptic cells.
They are the same shape as, but much smaller than, the end plate potentials caused by stimulation of the presynaptic cell. Miniature end plate potentials are considered as evidence for the quantal release of neurotransmitters at chemical synapses, a single miniature end plate potential resulting from the release of the contents of a single synaptic vesicle.
(12 Jan 1998)
water potential <plant biology> The chemical potential (i.e. Free energy per mole) of water in plants. Water moves within plants from regions of high water potential to regions of lower water potential, i.e. Down gradient.
(18 Nov 1997)
myogenic potential Action potential of muscle.
(05 Mar 2000)
postsynaptic potential In a synapse, a change in the resting potential of a postsynaptic cell following stimulation of the presynaptic cell. For example: in a cholinergic synapse, the release of acetylcholine from the presynaptic cell causes channels to open in the postsynaptic cell. Each channel opening causes a small depolarisation, known as a miniature end plate potential (mepp), these sum to produce an excitatory postsynaptic potential.
(18 Nov 1997)
potential Existing and ready for action but not yet active.
(18 Nov 1997)
potential energy <chemistry> Energy due to position, it is stored energy which can be used to do work.
(09 Jan 1998)
site potential tree A tree that has attained the average maximum height possible given site conditions where it occurs.
(05 Dec 1998)
somatosensory evoked potential The computer-averaged cortical and subcortical responses to repetitive stimulation of peripheral nerve sensory fibres.
(05 Mar 2000)
spike potential The main wave in the action potential of a nerve; it is followed by negative and positive afterpotentials.
(05 Mar 2000)
S potential Prolonged, slow, depolarising or hyperpolarising responses to illumination; initiated between the photoreceptor and ganglion cell layers of the retina.
(05 Mar 2000)
Nernst potential See: Nernst equation and ion selective electrodes.
(18 Nov 1997)
surface potential <cell biology, physiology> The electrostatic potential due to surface charged groups and adsorbed ions at a surface.
It is usually measured as the zeta potential at the Helmholtz slipping plane outside the surface.
(19 Jan 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á